Welcome! If you have any pricing inquiries, please don't hesitate to reach out to us using the form on the left side. We'll respond to you promptly.
Through our expertise in material sciences and formulation engineering, CD Formulation has generated a unique E. coli (EC) cytomembrane encapsulated nanoparticle technology. Our integrated services include membrane extraction and characterization, nanoparticle development with customizable payloads, and analytical testing to optimize delivery properties.
Preparation of nanoparticles based on E. coli cytomembrane (Zhao X.; et al. 2022)
Our team specializes in using cell engineering techniques to optimize EC strains to achieve higher membrane yields. We can also customize the phenotypic characteristics of strains according to customer needs, such as the expression of surface marker proteins.
We select appropriate growth conditions based on the characteristics of the strains, such as nutrient-rich media and appropriate temperatures to achieve high cell density.
Harvested EC cells are subjected to cell disruption methods such as sonication or homogenization to release the cell membrane.
Bacterial cell membranes are isolated and purified from cell lysates using membrane extraction techniques such as differential centrifugation or membrane filtration.
Factors such as molecular weight, structure, charge and stability profile are thoroughly evaluated to inform the rational design of optimized carrier systems.
Tailorable nanomaterials and formulation conditions are selected to effectively encapsulate and protect the cargo from degradation while maintaining controlled release kinetics.
Hydrophobic and electrostatic interactions are carefully modulated to fully complex and store nucleic acids within a biocompatible membrane.
At CD Formulation, we have developed a versatile platform for generating hybrid biomimetic vesicles through the controlled mixing of bacterial cell membranes with membranes from other sources. Our process allows for the precise incorporation of select membrane components derived from mammalian, plant or microbial cells. By modulating the ratios and compositions of the mixed membranes, we can engineer vesicles with tailored surface properties, targeting abilities, and biocompatibility profiles.
Parameter | Equipment/Technology | Content |
Size and Dispersion | Nanoparticle Tracking Analysis (NTA) | Measure particle size distribution and concentration |
Morphology | Transmission Electron Microscopy (TEM) | Visualize nanoparticle shape, structure and membrane coating |
Surface Charge | Zeta Potential Analysis | Determine surface charge/electrophoretic mobility |
Encapsulation Efficiency | High Performance Liquid Chromatography (HPLC) | Quantify the amount and purity of the encapsulated cargo |
Release Kinetic | UV-Vis Spectroscopy | Monitor the in vitro release profile of the encapsulated cargo |
Membrane Protein | SDS-PAGE and Western Blot | Assess membrane protein content, structure and integrity |
Cellular Uptake | Flow Cytometry | Quantitatively measure nanoparticle association/internalization |
Cytotoxicity | MTT Assay | Evaluate biocompatibility and cytotoxic potential |
Discover the potential of EC cytomembrane-coated nanoparticle development with our comprehensive services. CD Formulation specializes in isolating cytomembranes from diverse bacterial sources, enabling the biomimetic coating of customizable nanoparticle cores. Contact us today to embark on a transformative journey of using biomimetic nanoparticles to deliver nucleic acid-based therapeutics!
References